DL-3-n-butylphthalide

DRUG3 trials

Sponsors

Shanghai 6th People's Hospital, First Affiliated Hospital Xi'an Jiaotong University, First Hospital of China Medical University

Conditions

Acute Cerebral Stroke Within 12 Hours for the First TimeAlzheimer's DiseaseChemotherapy-Related Cognitive ImpairmentDL-3-n-butylphthalide

Phase 1

Dl-3-n-butylphthalide and Cerebrolysin Treatment in Acute Ischemic Stroke

CompletedNCT02149875

Shanghai 6th People's HospitalAcute Cerebral Stroke Within 12 Hours for the First Time

Start: 2010-01-31End: 2010-05-31Updated: 2020-08-24

Phase 4

Effects of DL-3-n-butylphthalide on Chemotherapy-Induced Cognitive Impairment

Not yet recruitingNCT06508671

First Hospital of China Medical UniversityChemotherapy-Related Cognitive Impairment, DL-3-n-butylphthalide

Start: 2024-07-31End: 2026-12-31Target: 100Updated: 2024-07-18

Unknown Phase

DL-3-n-butylphthalide Treatment in Patients With Mild to Moderate Alzheimer's Disease Already Receiving Donepezil

CompletedNCT02711683

First Affiliated Hospital Xi'an Jiaotong UniversityAlzheimer's Disease

Start: 2016-03-31End: 2019-12-31Updated: 2020-02-12

Related Papers

Efficacy and safety comparison of DL-3-n-butylphthalide and Cerebrolysin: Effects on neurological and behavioral outcomes in acute ischemic stroke

Experimental and Therapeutic Medicine2016-03-1068 citations